176 related articles for article (PubMed ID: 38015853)
1. Characterization and applications of glutaminase free L-asparaginase from indigenous Bacillus halotolerans ASN9.
Shafqat I; Shahzad S; Yasmin A; Chaudhry MT; Ahmed S; Javed A; Afzal I; Bibi M
PLoS One; 2023; 18(11):e0288620. PubMed ID: 38015853
[TBL] [Abstract][Full Text] [Related]
2. Production and Anticancer Activity of an L-Asparaginase from Bacillus licheniformis Isolated from the Red Sea, Saudi Arabia.
Alrumman SA; Mostafa YS; Al-Izran KA; Alfaifi MY; Taha TH; Elbehairi SE
Sci Rep; 2019 Mar; 9(1):3756. PubMed ID: 30842557
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of glutaminase-free L-asparaginases from Himalayan Pseudomonas and Rahnella spp. for acrylamide mitigation.
Patial V; Kumar S; Joshi R; Singh D
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128576. PubMed ID: 38048933
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous properties.
Mahajan RV; Kumar V; Rajendran V; Saran S; Ghosh PC; Saxena RK
PLoS One; 2014; 9(6):e99037. PubMed ID: 24905227
[TBL] [Abstract][Full Text] [Related]
5. Glutaminase-free L-asparaginase production by
Freire RKB; Mendonça CMN; Ferraro RB; Moguel IS; Tonso A; Lourenço FR; Santos JHPM; Sette LD; Pessoa Junior A
Prep Biochem Biotechnol; 2021; 51(3):277-288. PubMed ID: 32921254
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines.
Saeed H; Hemida A; El-Nikhely N; Abdel-Fattah M; Shalaby M; Hussein A; Eldoksh A; Ataya F; Aly N; Labrou N; Nematalla H
Int J Biol Macromol; 2020 Aug; 156():812-828. PubMed ID: 32311402
[TBL] [Abstract][Full Text] [Related]
7. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
[TBL] [Abstract][Full Text] [Related]
8. Purification and biotechnological applications of L-asparaginase from newly isolated
El-Fakharany E; Orabi H; Abdelkhalek E; Sidkey N
J Biomol Struct Dyn; 2022 Jun; 40(9):3837-3849. PubMed ID: 33228468
[TBL] [Abstract][Full Text] [Related]
9. Production, purification and kinetic characterization of glutaminase free anti-leukemic L-asparaginase with low endotoxin level from novel soil isolate.
Prakash P; Singh HR; Jha SK
Prep Biochem Biotechnol; 2020; 50(3):260-271. PubMed ID: 31762381
[TBL] [Abstract][Full Text] [Related]
10. Aliivibrio fischeri L-Asparaginase production by engineered Bacillus subtilis: a potential new biopharmaceutical.
Bento HBS; Paiva GB; Almeida MR; Silva CG; Carvalho PJ; Tavares APM; Pedrolli DB; Santos-Ebinuma VC
Bioprocess Biosyst Eng; 2022 Oct; 45(10):1635-1644. PubMed ID: 35974197
[TBL] [Abstract][Full Text] [Related]
11. Purification, characterization, and anticancer and antioxidant activities of L-glutaminase from Aspergillus versicolor Faesay4.
Awad MF; El-Shenawy FS; El-Gendy MMAA; El-Bondkly EAM
Int Microbiol; 2021 May; 24(2):169-181. PubMed ID: 33389217
[TBL] [Abstract][Full Text] [Related]
12. A new extracellular glutaminase and urease-free L-asparaginase from Meyerozyma guilliermondii.
Ratuchne A; Izidoro SC; Beitel SM; Lacerda LT; Knob A
Braz J Microbiol; 2023 Jun; 54(2):715-723. PubMed ID: 36917331
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
[TBL] [Abstract][Full Text] [Related]
14. Purification and anticancer activity of glutaminase and urease free intracellular l-asparaginase from Chaetomium sp.
Arumugam N; Thangavelu P
Protein Expr Purif; 2022 Feb; 190():106006. PubMed ID: 34742913
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
Kumar S; Venkata Dasu V; Pakshirajan K
Bioresour Technol; 2011 Jan; 102(2):2077-82. PubMed ID: 20832300
[TBL] [Abstract][Full Text] [Related]
16. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
[TBL] [Abstract][Full Text] [Related]
17. Indicator dye based screening of glutaminase free L-asparaginase producer and kinetic evaluation of enzyme production process.
Prakash P; Singh HR; Jha SK
Prep Biochem Biotechnol; 2020; 50(8):803-813. PubMed ID: 32163010
[TBL] [Abstract][Full Text] [Related]
18. Rational engineering and insight for a L-glutaminase activity reduced type II L-asparaginase from Bacillus licheniformis and its antileukemic activity in vitro.
Zhou Y; Shen J; Chi H; Zhu X; Lu Z; Lu F; Zhu P
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128690. PubMed ID: 38092107
[TBL] [Abstract][Full Text] [Related]
19. A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.
Sugimoto K; Suzuki HI; Fujimura T; Ono A; Kaga N; Isobe Y; Sasaki M; Taka H; Miyazono K; Komatsu N
Cancer Sci; 2015 Nov; 106(11):1534-43. PubMed ID: 26331698
[TBL] [Abstract][Full Text] [Related]
20. Development and catalytic characterization of L-asparaginase nano-bioconjugates.
Agrawal S; Kango N
Int J Biol Macromol; 2019 Aug; 135():1142-1150. PubMed ID: 31170492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
